2020
DOI: 10.1007/s40620-020-00864-4
|View full text |Cite
|
Sign up to set email alerts
|

Prevention of hypomagnesemia in critically ill patients with acute kidney injury on continuous kidney replacement therapy: the role of early supplementation and close monitoring

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 24 publications
(9 citation statements)
references
References 64 publications
0
8
0
1
Order By: Relevance
“…Finally, hypomagnesemia, generally defined as serum magnesium levels <0.70 mmol/l and commonly classified as mild, moderate, and severe (respectively between 0.76 and 0.64, between 0.63 and 0.40 and <0.40 mmol/l), has been reported in up to 12% of hospitalized patients with an incidence around 60e65% among critically ill patients [252,253]. In addition to the most common causes (such as diarrhea, malabsorption syndrome, chronic use of proton pump inhibitors and diuretics, hypercalcemia, and volume expansion), increased attention has recently been directed to the increased magnesium removal in course of KRT [254]. In particular, the onset and the exacerbation of hypomagnesemia in course of CKRT have been associated not only to the depurative mechanism at the basis of dialysis treatment (diffusive or convective clearance) but also to the amount of ionized magnesium chelated by citrate when regional citrate anticoagulation is utilized and magnesium is lost in the effluent under the form of magnesiumecitrate complexes [246,255e258].…”
Section: Would Adding Glutamine Supplements Lead To Improved Outcomes?mentioning
confidence: 99%
“…Finally, hypomagnesemia, generally defined as serum magnesium levels <0.70 mmol/l and commonly classified as mild, moderate, and severe (respectively between 0.76 and 0.64, between 0.63 and 0.40 and <0.40 mmol/l), has been reported in up to 12% of hospitalized patients with an incidence around 60e65% among critically ill patients [252,253]. In addition to the most common causes (such as diarrhea, malabsorption syndrome, chronic use of proton pump inhibitors and diuretics, hypercalcemia, and volume expansion), increased attention has recently been directed to the increased magnesium removal in course of KRT [254]. In particular, the onset and the exacerbation of hypomagnesemia in course of CKRT have been associated not only to the depurative mechanism at the basis of dialysis treatment (diffusive or convective clearance) but also to the amount of ionized magnesium chelated by citrate when regional citrate anticoagulation is utilized and magnesium is lost in the effluent under the form of magnesiumecitrate complexes [246,255e258].…”
Section: Would Adding Glutamine Supplements Lead To Improved Outcomes?mentioning
confidence: 99%
“…Due to decreased excretion, magnesium levels classically increase in AKI, though many critically ill patients develop hypomagnesemia [136][137][138]. Hence, the nutritional delivery of magnesium is adjusted based on serum levels.…”
Section: Carnitinementioning
confidence: 99%
“…Magnesium spielt eine wichtige Rolle bei der Kontrolle der Herzfrequenz, der Muskelkontraktion und -relaxation, der nervalen Reizübermittlung und des vaskulären Tonus. Aus diesem Grund sollte auch eine Hypomagnesiämie korrigiert werden [ 15 ]. Eine Hypomagnesiämie kann auch im Zusammenhang mit einem Refeedingsyndrom auftreten und insbesondere einen paralytischen Ileus bzw.…”
Section: Laborchemisches Monitoring Der Mntunclassified